Iankov, I D <br/><br/>
Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy.  [electronic resource] 

 -  Cancer gene therapy  Sep 2015 
 - 438-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5500 
<br/><br/><label>Standard No.: </label>10.1038/cgt.2015.36  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--secondary<br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Aurora Kinase B--antagonists & inhibitors<br/>Azepines--pharmacology<br/>Bacterial Proteins--genetics<br/>Breast Neoplasms--pathology<br/>Chlorocebus aethiops<br/>Combined Modality Therapy<br/>Female<br/>Gene Expression Regulation<br/>Humans<br/>Immunoglobulin lambda-Chains--genetics<br/>Interleukins--biosynthesis<br/>Lung Neoplasms--secondary<br/>Measles virus<br/>Mice<br/>Mice, Nude<br/>Oncolytic Virotherapy<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrimidines--pharmacology<br/>Transgenes<br/>Vero Cells<br/>Xenograft Model Antitumor Assays